According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is $3.97. In 2022 the company made an earnings per share (EPS) of $2.98 a decrease over its 2021 EPS that were of $3.17.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $3.97 | 33.22% |
2022 | $2.98 | -6.04% |
2021 | $3.17 | -179.29% |
2020 | -$4.00 | -281.37% |
2019 | $2.21 | -27.21% |
2018 | $3.03 | 388.71% |
2017 | $0.62 | -76.78% |
2016 | $2.67 | 175.26% |
2015 | $0.97 | -19.83% |
2014 | $1.21 | -22.44% |
2013 | $1.56 | 34.48% |
2012 | $1.16 | -47.03% |
2011 | $2.19 | 21.67% |
2010 | $1.80 | -66.36% |
2009 | $5.35 | 104.2% |
2008 | $2.62 | 140.37% |
2007 | $1.09 | 36.25% |
2006 | $0.80 | -47.37% |
2005 | $1.52 | 23.58% |
2004 | $1.23 | -23.6% |
2003 | $1.61 | 50.47% |
2002 | $1.07 | 1.9% |
2001 | $1.05 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | 254.79% | ๐บ๐ธ USA |
Novartis NVS | $3.74 | -5.79% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | -53.15% | ๐บ๐ธ USA |
AbbVie ABBV | $3.68 | -7.29% | ๐บ๐ธ USA |
Eli Lilly LLY | $5.43 | 36.76% | ๐บ๐ธ USA |
Amgen AMGN | $14.15 | 256.42% | ๐บ๐ธ USA |
Sanofi SNY | $3.18 | -19.89% | ๐ซ๐ท France |
Biogen BIIB | $18.46 | 364.99% | ๐บ๐ธ USA |
Merck MRK | $1.82 | -54.11% | ๐บ๐ธ USA |
AstraZeneca AZN | $1.98 | -50.00% | ๐ฌ๐ง UK |